Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.830
+0.030 (1.07%)
At close: May 9, 2025, 4:00 PM
2.720
-0.110 (-3.89%)
After-hours: May 9, 2025, 4:05 PM EDT
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $37.31 million as of May 9, 2025. Its market cap has increased by 36.89% in one year.
Market Cap
37.31M
Enterprise Value
26.26M
1-Year Change
36.89%
Ranking
Category
Stock Price
2.83
Market Cap Chart
Since October 24, 2011, Grace Therapeutics's market cap has decreased from $87.20M to $37.31M, a decrease of -57.21%. That is a compound annual growth rate of -6.07%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 674.60B |
| Johnson & Johnson | 374.53B |
| UnitedHealth Group | 350.94B |
| AbbVie | 328.29B |
| Novo Nordisk | 287.72B |
| Abbott Laboratories | 233.14B |
| Novartis AG | 215.89B |
| AstraZeneca | 208.98B |